Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rui Kang Pharmaceutical Group Investments Ltd proposes rights issue


Wednesday, 20 Aug 2014 09:16am EDT 

Rui Kang Pharmaceutical Group Investments Ltd:Proposes to raise not less than about HK$53.6 mln before expenses by issuing not less than 335,208,000 rights shares and not more than about HK$57.2 mln before expenses by issuing not more than 357,508,000 rights shares.Says on the basis of one rights share for every two existing shares in issue held on the record date at the subscription price of HK$0.16 per rights share.Intends to apply net proceeds for funding acquisition and for general working capital. 

Company Quote